Poterala JE, Havighurst T, Braun Wisinski K. Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies. Clin Breast Cancer 2022 May 5. pii: S1526-8209(22)00080.
PMID: 35676188